Prevention and Treatment of Infectious Complications After Solid Organ Transplantation in Children

Pediatric Clinics of North America

Volumn 57, Issue 2, 2010, Pages 459-479

  Allen, Upton ^a,b   Green, Michael ^c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Infections; Pediatric; Posttransplant; Prophylaxis; Transplantation

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ATOVAQUONE; CIDOFOVIR; COTRIMOXAZOLE; DAPSONE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FAMCICLOVIR; FANSIDAR; FLUCONAZOLE; GANCICLOVIR; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; ITRACONAZOLE; IVERMECTIN; MENINGOCOCCUS VACCINE; NYSTATIN; OSELTAMIVIR; PENTAMIDINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RIBAVIRIN; UNINDEXED DRUG; VALACICLOVIR; VALGANCICLOVIR; VARICELLA ZOSTER VACCINE; VORICONAZOLE; WART VIRUS VACCINE; ZANAMIVIR;

ADENOVIRUS INFECTION; ANTIVIRAL ACTIVITY; ASPERGILLOSIS; BACTERIAL INFECTION; BK VIRUS; CANDIDIASIS; CHILD HEALTH; CYTOMEGALOVIRUS INFECTION; DIPHTHERIA; DISEASE COURSE; EPSTEIN BARR VIRUS INFECTION; HAEMOPHILUS INFECTION; HEPATITIS B; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; IMMUNIZATION; INFLUENZA; MENINGOCOCCEMIA; MYCOSIS; ORGAN DONOR; ORGAN TRANSPLANTATION; PAPILLOMAVIRUS INFECTION; PERTUSSIS; PNEUMOCOCCAL INFECTION; PNEUMOCYSTIS PNEUMONIA; POLIOMYELITIS; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; REVIEW; RISK FACTOR; SCREENING TEST; SEROLOGY; STRONGYLOIDIASIS; TETANUS; TOXOPLASMOSIS; TUBERCULIN TEST; TUBERCULOSIS; VIRUS INFECTION;

CHILD; HUMANS; IMMUNIZATION; IMMUNOSUPPRESSION; INFECTION; INFECTION CONTROL; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION; RISK FACTORS; TISSUE DONORS;

EID: 77950997644     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2010.01.005     Document Type: Review

References (74)

1. Fishman J.A., Rubin R.H. Infection in organ-transplant recipients. N Engl J Med 1998, 338:1741-1751.
2. Rubin R.H., Wolfson J.S., Cosimi A.B., et al. Infection in the renal transplant patient. Am J Med 1981, 70:405-411.
3. Rubin R., Ikonen T., Gummert J., et al. The therapeutic prescription for the organ transplant recipient: the linkage of immunosuppression and antimicrobial strategies. Transpl Infect Dis 1999, 1(1):29-39.
4. Krieger J.N., Brem A.S., Kaplan M.R. Urinary tract infection in pediatric renal transplantation. Urology 1980, 15(4):362-369.
5. Zitelli B.J., Gartner J.C., Malatack J.J., et al. Pediatric liver transplantation: patient evaluation and selection, infectious complications, and life-style after transplantation. Transplant Proc 1987, 19(4):3309-3316.
6. Colonna J.O., Winston D.J., Brill J.E., et al. Infectious complications in liver transplantation. Arch Surg 1988, 123(3):360-364.
7. Sigurdsson L., Reyes J., Kocoshis S.A., et al. Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease. Transplantation 2000, 70(2):302-305.
8. Green M., Bueno J., Sigurdsson L., et al. Unique aspects of the infectious complications of intestinal transplantation. Curr Opin Organ Transplant 1999, 4(4):361-367.
9. Green M., Wald E.R., Fricker F.J., et al. Infections in pediatric orthotopic heart transplant recipients. Pediatr Infect Dis J 1989, 8(2):87-93.
10. Baum D., Bernstein D., Starnes V.A., et al. Pediatric heart transplantation at Stanford: results of a 15-year experience. Pediatrics 1991, 88(2):203-214.
11. Bailey L.L., Wood M., Razzouk A., et al. Heart transplantation during the first 12 years of life. Loma Linda University Pediatric Heart Transplant Group. Arch Surg 1989, 124(10):1221-1225.
12. Braunlin E.A., Canter C.E., Olivari M.T., et al. Rejection and infection after pediatric cardiac transplantation. Ann Thorac Surg 1990, 49(3):385-390.
13. Noyes B.E., Michaels M.G., Kurland G., et al. Pseudomonas cepacia empyema necessitatis after lung transplantation in two patients with cystic fibrosis. Chest 1994, 105(6):1888-1891.
14. De Soyza A., McDowell A., Archer L., et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001, 358(9295):1780-1781.
15. Aris R.M., Routh J.C., LiPuma J.J., et al. Lung transplantation for cystic fibrosis, patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001, 164(11):2102-2106.
16. LiPuma J.J. Update on the Burkholderia cepacia complex. Curr Opin Pulm Med 2005, 11(6):528-533.
17. Tran L., Hébert D., Dipchand A., et al. Invasive pneumococcal disease in pediatric organ transplant recipients: a high-risk population. Pediatr Transplant 2005, 9(2):183-186.
18. Verma A., Wade J.J., Cheeseman P., et al. Risk factors for fungal infection in paediatric liver transplant recipients. Pediatr Transplant 2005, 9(2):220-225.
19. Schaenman J.M., Rosso F., Austin J.M., et al. Trends in invasive disease due to Candida species following heart and lung transplantation. Transpl Infect Dis 2009, 11(2):112-121.
20. van Hal S.J., Marriott D.J., Chen S.C., et al. Australian Candidemia Study. Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience. Transpl Infect Dis 2009, 11(2):122-127.
21. Weigt S.S., Elashoff R.M., Huang C., et al. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome. Am J Transplant 2009, 9(8):1903-1911.
22. Kotton C., Kumar D., Caliendo A., et al. On behalf of The Transplantation Society International CMV Consensus Group. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Am J Transplant 2010, 10(1):18-25.
23. Green M., Michaels M.G., Katz B.Z., et al. CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Am J Transplant 2006, 6(8):1906-1912.
24. Danziger-Isakov L.A., DelaMorena M., Hayashi R.J., et al. Cytomegalovirus viremia associated with death or retransplantation in pediatric lung-transplant recipients. Transplantation 2003, 75(9):1538-1543.
25. Danziger-Isakov LA, Worley S, Michaels MG, et al. The risk, prevention & outcome of cytomegalovirus after pediatric lung transplantation. Transplantation, in press.
26. Pillay D., Ali A.A., Liu S.F., et al. The prognostic significance of positive CMV cultures during surveillance of renal transplant recipients. Transplantation 1993, 56(1):103-108.
27. Storch G.A., Ettinger N.A., Ockner D., et al. Quantitative cultures of the cell fraction and supernatant of bronchoalveolar lavage fluid for the diagnosis of cytomegalovirus pneumonitis in lung transplant recipients. J Infect Dis 1993, 168(6):1502-1506.
28. Buffone G.J., Frost A., Samo T., et al. The diagnosis of CMV pneumonitis in lung and heart/lung transplant patients by PCR compared with traditional laboratory criteria. Transplantation 1993, 56(2):342-347.
29. Asberg A., Humar A., Jardine A.G., et al. Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients. Am J Transplant 2009, 9(5):1205-1213.
30. Monforte V., Lopez C., Santos F., et al. A multicenter study of valganciclovir prophylaxis up to day 120 in CMV-seropositive lung transplant recipients. Am J Transplant 2009, 9(5):1134-1141.
31. Vaudry W., Ettenger R., Jara P., et al. Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients. Am J Transplant 2009, 9(3):636-643.
32. American Academy of Pediatricas Epstein-Barr virus infections. Red Book. 2009 report of the Committee on infectious diseases 2009, 289-292. American Academy of Pediatrics, Elk Grove Village (IL). 28th edition. L.K. Pickering, C.J. Baker, D.W. Kimberlin (Eds.).
33. Nur S., Rosenblum W.D., Katta U.D., et al. Epstein-Barr virus-associated multifocal leiomyosarcomas arising in a cardiac transplant recipient: autopsy case report and review of the literature. J Heart Lung Transplant 2007, 26(9):944-952.
34. Green M. Management of Epstein-Barr virus-induced posttransplant lymphoproliferative disease in recipients of solid organ transplantation. Am J Transplant 2001, 1(2):103-108.
35. Preiksaitis J.K. New developments in the diagnosis and management of posttransplantation lympholiferative disorders in solid organ transplant recipients. Clin Infect Dis 2004, 39(7):1016-1023.
36. de Mezerville M.H., Tellier R., Richardson S., et al. Adenoviral infections in pediatric transplant recipients: a hospital-based study. Pediatr Infect Dis J 2006, 25(9):815-818.
37. American Academy of Pediatricas Adenovirus infections. Red Book. 2009 report of the Committee on Infectious Diseases 2009, 204-206. American Academy of Pediatrics, Elk Grove Village (IL). 28th edition. L.K. Pickering, C.J. Baker, D.W. Kimberlin (Eds.).
38. Hoffman J.A., Shah A.J., Ross L.A., et al. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001, 7(7):388-394.
39. Babel N., Fendt J., Karaivanov S., et al. Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples. Transplantation 2009, 88(1):89-95.
40. Vats A., Shapiro R., Singh Randhawa P., et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003, 75(1):105-112.
41. Pandya A., Wasfy S., Hébert D., et al. Varicella Zoster infection in solid organ transplant recipients: a hospital-based retrospective study. Pediatr Transplant 2001, 5(3):1-9.
42. Whitley R.J. Varicella zoster virus. Principles and practice of infectious diseases 2000, 1580-1585. Churchill Livingstone, Philadelphia. 5th edition. G.C. Mandell, J.E. Bennett, R. Dolin (Eds.).
43. Barton M., Wasfy S., Melbourne T., et al. Sustainability of humoral responses to varicella vaccine in pediatric transplant recipients following a pre-transplantation immunization strategy. Pediatr Transplant 2008, 13(8):1007-1013.
44. American Academy of Pediatricas Varicella-zoster infections. Red Book. 2009 report of the Committee on Infectious Diseases 2009, 714-727. American Academy of Pediatrics, Elk Grove Village (IL). 28th edition. L.K. Pickering, C.J. Baker, D.W. Kimberlin (Eds.).
45. Pohl C., Green M., Wald E.R., et al. Respiratory syncytial virus infections in pediatric liver transplant recipients. J Infect Dis 1992, 165(1):166-169.
46. Apalsch A.M., Green M., Ledesma-Medina J., et al. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995, 20(2):394-399.
47. Scalera N.M., Mossad S.B. The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus. Postgrad Med 2009, 121(5):43-47.
48. Centers for Disease Control and Prevention Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009, 58:1-3.
49. Kumar D., Morris M.I., Kotton C.N., et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant 2010, 10(1):18-25.
50. Schafers H.J., Cremer J., Wahlers T., et al. Pneumocystis carinii pneumonia following heart transplantation. Eur J Cardiothorac Surg 1987, 1(1):49-52.
51. Gryzan S., Paradis I.L., Zeevi A., et al. Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis 1988, 137(6):1268-1274.
52. American Academy of Pediatricas Pneumocystis jirovecii infections. Red Book. 2009 report of the Committee on Infectious Diseases 2009, 536-540. American Academy of Pediatrics, Elk Grove Village (IL). 28th edition. L.K. Pickering, C.J. Baker, D.W. Kimberlin (Eds.).
53. Luft B.J., Naot Y., Araujo F.G., et al. Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population. Ann Intern Med 1983, 99(1):27-31.
54. Michaels M.G., Wald E.R., Fricker F.J., et al. Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis 1992, 14(4):847-851.
55. Scoggin C.H., Call N.B. Acute respiratory failure due to disseminated strongyloidiasis in a renal transplant recipient. Ann Intern Med 1977, 87(4):456-458.
56. Nolan T.J., Schad G.A. Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis. Transplantation 1996, 62(7):1038.
57. Sternecik M., Ferrell S., Asher N., et al. Mycobacterial infection after liver transplantation: a report of three cases and review of the literature. Clin Transplant 1992, 6:55-61.
58. Higgins R., Kusne S., Reyes J., et al. Mycobacterium tuberculosis after liver transplantation: management and guidelines for prevention. Clin Transplant 1992, 6:81-90.
59. Singh N., Paterson D.L. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis 1998, 27(5):1266-1277.
60. American Society of Transplantation Infectious Diseases Community of Practice Mycobacterium tuberculosis. Am J Transplant 2004, 10(Suppl 4):37-41.
61. Detjen A.K., Keil T., Roll S., et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007, 45(3):322-328.
62. Okada K., Mao T.E., Mori T., et al. Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children. Epidemiol Infect 2008, 136(9):1179-1187.
63. Barton M., Wasfy S., Dipchand A., et al. Seven-valent pneumococcal conjugate vaccine in pediatric solid organ transplant recipients: a prospective study of safety and immunogenicity. Pediatr Infect Dis J 2009, 28(8):688-692.
64. Madan R.P., Tan M., Fernandez-Sesma A., et al. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis 2008, 46(5):712-718.
65. Arslan M., Wiesner R.H., Sievers C., et al. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Liver Transpl 2001, 7(4):314-320.
66. Carey W., Pimentel R., Westveer M.K., et al. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am J Gastroenterol 1990, 85(12):1590-1592.
67. Stark K., Gunther M., Neuhaus R., et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 1999, 180(6):2014-2017.
68. Balloni A., Assael B.M., Ghio L., et al. Immunity to poliomyelitis, diphtheria and tetanus in pediatric patients before and after renal or liver transplantation. Vaccine 1999, 17(20-21):2507-2511.
69. Lin P.L., Michaels M.G., Green M., et al. Safety and immunogenicity of the American Academy of Pediatrics-recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. Pediatrics 2005, 116(1):160-167.
70. Centers for Disease Control and Prevention Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4). MMWR Morb Mortal Wkly Rep 2008, 57(17):462-465.
71. Olson A.D., Shope T.C., Flynn J.T. Pretransplant varicella vaccination is cost-effective in pediatric renal transplantation. Pediatr Transplant 2001, 5(1):44-50.
72. Danziger-Isakov L., Kumar D., AST Infectious Diseases Community of Practice Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2009, 9(Suppl 4):S258-S262.
73. Weinberg A., Horslen S.P., Kaufman S.S., et al. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant 2006, 6(3):565-568.
74. Humar A., Morris M., Blumberg E., et al. Special report. Nucleic acid testing (NAT) of organ donors: is the " best" test the right test?. Am J Transplant 2010, [Epub ahead of print].